Perigon Wealth Management LLC grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3,382.5% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,194 shares of the medical equipment provider’s stock after buying an additional 2,131 shares during the period. Perigon Wealth Management LLC’s holdings in Intuitive Surgical were worth $1,050,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in ISRG. Adviser Investments LLC acquired a new position in shares of Intuitive Surgical during the 2nd quarter worth approximately $115,000. McKinley Carter Wealth Services Inc. acquired a new stake in shares of Intuitive Surgical during the 1st quarter worth approximately $132,000. Kaizen Advisory LLC boosted its position in shares of Intuitive Surgical by 156.0% during the 2nd quarter. Kaizen Advisory LLC now owns 279 shares of the medical equipment provider’s stock worth $133,000 after acquiring an additional 170 shares in the last quarter. Psagot Investment House Ltd. acquired a new stake in shares of Intuitive Surgical during the 2nd quarter worth approximately $133,000. Finally, Rockefeller Capital Management L.P. acquired a new stake in shares of Intuitive Surgical during the 2nd quarter worth approximately $142,000. 84.78% of the stock is owned by institutional investors.

Intuitive Surgical stock traded up $9.54 during midday trading on Friday, hitting $568.36. 840,350 shares of the stock were exchanged, compared to its average volume of 456,689. Intuitive Surgical, Inc. has a 52-week low of $337.80 and a 52-week high of $572.96. The stock has a market cap of $62.51 billion, a PE ratio of 79.05, a price-to-earnings-growth ratio of 4.02 and a beta of 0.86.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, July 19th. The medical equipment provider reported $2.76 earnings per share for the quarter, topping the consensus estimate of $2.02 by $0.74. The business had revenue of $909.30 million for the quarter, compared to analysts’ expectations of $877.43 million. Intuitive Surgical had a net margin of 23.20% and a return on equity of 20.56%. The firm’s revenue for the quarter was up 19.8% compared to the same quarter last year. During the same period in the previous year, the company earned $5.95 earnings per share. equities analysts predict that Intuitive Surgical, Inc. will post 9.31 EPS for the current fiscal year.

A number of analysts have weighed in on ISRG shares. Morgan Stanley raised their target price on shares of Intuitive Surgical from $525.00 to $535.00 and gave the company an “overweight” rating in a research report on Friday, June 1st. Zacks Investment Research lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, June 19th. Sanford C. Bernstein began coverage on shares of Intuitive Surgical in a research note on Wednesday, June 27th. They set an “outperform” rating and a $560.00 price target for the company. Bank of America raised their price target on shares of Intuitive Surgical from $510.00 to $600.00 and gave the company a “buy” rating in a research note on Tuesday, July 17th. Finally, Cantor Fitzgerald reissued a “buy” rating and set a $620.00 target price (up previously from $510.00) on shares of Intuitive Surgical in a research note on Friday, July 20th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $520.08.

In other news, Director Mark J. Rubash sold 150 shares of the business’s stock in a transaction that occurred on Monday, August 27th. The shares were sold at an average price of $543.66, for a total value of $81,549.00. Following the sale, the director now owns 4,116 shares of the company’s stock, valued at $2,237,704.56. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, VP Marshall Mohr sold 8,250 shares of the business’s stock in a transaction that occurred on Monday, July 30th. The shares were sold at an average price of $508.50, for a total transaction of $4,195,125.00. Following the completion of the sale, the vice president now directly owns 18,071 shares in the company, valued at approximately $9,189,103.50. The disclosure for this sale can be found here. In the last ninety days, insiders sold 109,463 shares of company stock worth $57,194,982. Insiders own 2.20% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Recommended Story: How Short Selling Works

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.